Urological oncology: a comparison between clinical and pathologic staging in patients with bladder cancer

A., Mehrsai; D., Mansoori; Mahmoodi M., Taheri; A., Sina; A., Seraji; G.H., Pourmand.
Urology Journal. 2004; 1 (2): 85-89
en Inglés | IMEMR | ID: emr-69190

Documentos relacionados

  1. Investigation of Atypical Cell Parameter in the Surveillance of Patients with NMIBC; Initial Outcomes of a Single Center Prospective Study.
  2. Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trial.
  3. A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients.
  4. Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 Amendment.
  5. The Role of Urine and Washing Cytology in Primary Transurethral Resection of Bladder Tumours.
  6. Evaluation of Urine NDRG1 as Noninvasive Biomarker for Bladder Cancer Diagnosis.
  7. [French ccAFU guidelines - update 2020-2022: bladder cancer].
  8. Deregulated Expression of <i>IL-37</i> in Patients with Bladder Urothelial Cancer: The Diagnostic Potential of the <i>IL-37e</i> Isoform.
  9. The accuracy of cystoscopy in predicting muscle invasion in newly diagnosed bladder cancer patients.
  10. The use of artificial intelligence for the diagnosis of bladder cancer: a review and perspectives.